Coronary/Structural Heart Boston Scientific says Lotus out until Next Year Shared by Ken Dropiewski on February 2, 2018 More in Coronary/Structural Heart: Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis January 30, 2025 AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia January 30, 2025 Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program January 30, 2025 Share this story Facebook Twitter LinkedIn Lotus Valve to Stay Off the Shelves Through 2018 Patrice Wendling – February 01, 2018, Medscape MARLBOROUGH, MA — The beleaguered Lotus heart valve system is not expected to launch in the US market until 2019, according to Boston Scientific officials. All Lotus valves were voluntarily recalled worldwide in February 2017 because of reports of early release of a pin connecting the transcatheter valve to the delivery system…. Read Full Article at Medscape here